Inmune Bio, Inc. identifies Clark Ronnie Duane as an insider with an initial stake. The report also identifies him as a director and associates the position with Form 3 and Form 4 statements, giving investors the named individual and regulatory forms tied to the change.
Key Highlights
- Clark Ronnie Duane is identified as an insider at Inmune Bio.
- The reported position is described as an initial stake.
- The regulatory record includes Form 3 and Form 4 statements.
Inmune Bio, Inc. (NASDAQ: INMB) is a biotechnology company. The record also identifies him as a director of Inmune Bio.
Clark Ronnie Duane’s Insider Position
Clark Ronnie Duane is named in a Form 3 connected with Inmune Bio. The document reports a new insider position for him at the company. The position is described as an initial stake. His name is also linked to a Form 4 insider statement.
FAQs
Q: Who is the newly reported insider at Inmune Bio?
A: Clark Ronnie Duane is the named insider at Inmune Bio, Inc. The record identifies him as a director of the biotechnology company.
Q: What type of position was reported for Clark Ronnie Duane?
A: The report describes an initial insider stake for Clark Ronnie Duane at Inmune Bio.
Q: Which regulatory forms are associated with the Inmune Bio insider position?
A: Clark Ronnie Duane’s position is associated with a Form 3 and a Form 4 insider statement. Both records relate to Inmune Bio.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.